Founded
31 Dec 1998

Address

Other Office
3535 South Tamarac Drive
Denver, CO 80237
United States

Open Map

Business classification

VCID: 3009
    Profile

    Corporate information

    Affiliate of


    Registration country
    Investment activity status
    Active investor

    Company type

    Division of ATEL Capital Group, is a leading provider of venture debt and equipment financing to emerging growth companies.

    Selected investments

    Country Date Notes
    Ipierian Inc
    Biopharmaceutical company using patient-derived induced pluripotent stem cells for drug discovery.
    United States 9 Sep 2010 Series B
    Initial investment. Round participant. Active
    SolFocus Inc
    United States 1 Apr 2010 Venture
    Active
    Nexplanar Corp
    United States 1 Mar 2010 Debt
    IntelePeer Inc
    United States 1 Oct 2009 Venture
    Active
    OpSource Inc
    United States 1 Aug 2009 Venture
    Enerkem Inc
    Canada 14 Jul 2009 Venture
    Active
    Innovalight Inc
    Developers of nano-materials, silicon ink based printed solar cells
    United States 7 Jul 2008 N/A
    Led the investment round. Active
    Reply! Inc
    United States 1 Oct 2007 Series C
    Arbinet Corp
    United States N/A
    Cedar Point Communications Inc
    United States N/A
    Doppelganger Inc
    United States N/A
    InfiniRoute Networks Inc
    United States N/A
    Locus Pharmaceuticals Inc
    United States N/A
    Renew Data Corp
    United States N/A
    STEP Labs Inc
    United States N/A
    Altierre Corp
    United States N/A
    Active
    Arsenal Digital Solutions USA Inc
    United States N/A
    Chelsio Communications Inc
    Fabless semiconductor manufacturer focused on host bus adapters.
    United States N/A
    Dorado Corp
    United States N/A
    Metabolon Inc
    Provider of biomarker discovery and analysis
    United States N/A

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.